Skip to main content

Tirzepatide Dosing Calculator

Tirzepatide: FDA-approved dual GIP/GLP-1 agonist with up to 22.5% weight loss.

Pre-filled with the most-reported community reconstitution protocol for Tirzepatide. See how 1 mL and 2 mL of bacteriostatic water change concentration and syringe-draw volume, then adjust the calculator below for your own vial.

Quick answer · Community-reported standard

A 15 mg vial of Tirzepatide reconstituted with 2 mL of bacteriostatic water yields a concentration of 7.50 mg/mL. At that concentration, a 2.5 mg dose of Tirzepatide equals 33.3 units on a U-100 insulin syringe (0.333 mL). Tirzepatide is typically administered once weekly via subcutaneous.

Tirzepatide reconstitution: 1 mL vs 2 mL bac water

Bacteriostatic water volume is flexible. Less water means higher concentration and smaller injection volumes; more water means lower concentration and easier dose precision. Both options below are valid for a 15 mg vial.

BAC water addedConcentrationVolume per 2.5 mg doseDraw on U-100 syringe (units)
1 mL15.00 mg/mL0.167 mL16.7 units
2 mL7.50 mg/mL0.333 mL33.3 units
Based on a 15 mg vial of Tirzepatide reconstituted with bacteriostatic water. Insulin-syringe units assume a standard U-100 syringe (100 units = 1 mL).

Calculate your Tirzepatide dose

Alternative Tirzepatide protocols

Beyond the default above, Tirzepatide is also reported in the following protocols. Use these as starting points and recalculate with the tool above.

Compounded Tirzepatide Protocol

Community
Dose
2.5-15 mg
Frequency
Once weekly
Duration
Ongoing
Route
Subcutaneous

Uses compounded vials (various concentrations); requires dose calculator tools like Fat Scientist; community reports dosing in units rather than mg

Moderate Maintenance Protocol

Community
Dose
7.5-10 mg
Frequency
Once weekly
Duration
Ongoing
Route
Subcutaneous

Many community members stabilize at 7.5-10 mg rather than escalating to maximum 15 mg dose; reports adequate weight loss with fewer GI side effects

Split-Dose Protocol

Community
Dose
5-15 mg (split into 2 injections)
Frequency
2 times weekly (splitting weekly dose)
Duration
Ongoing
Route
Subcutaneous

Some users split their weekly dose into two injections 3-4 days apart to maintain more consistent drug levels and reduce peak-related side effects

Type 2 Diabetes (Mounjaro)

Clinical
Dose
Start 2.5 mg weekly SC for 4 weeks, then escalate to 5 mg weekly. May increase by 2.5 mg increments every 4 weeks to maximum 15 mg weekly.
Frequency
Once weekly subcutaneous injection
Duration
Ongoing; long-term maintenance therapy

2.5 mg is the starting dose for GI tolerability, not a therapeutic dose. Minimum therapeutic dose is 5 mg. Dose escalation: 2.5 mg -> 5 mg -> 7.5 mg -> 10 mg -> 12.5 mg -> 15 mg. Each increase after at least 4 weeks.

Weight Management (Zepbound)

Clinical
Dose
Start 2.5 mg weekly SC for 4 weeks, then escalate to 5 mg weekly. May increase by 2.5 mg increments every 4 weeks. Target maintenance dose is typically 10 mg or 15 mg weekly.
Frequency
Once weekly subcutaneous injection
Duration
Ongoing; long-term weight management

Same escalation schedule as Mounjaro. Higher maintenance doses (10-15 mg) generally needed for maximal weight loss efficacy. If patient does not tolerate a dose increase, consider maintaining current dose or returning to previously tolerated dose.

Tirzepatide reconstitution & storage

Tirzepatide is supplied as a pre-filled, single-dose pen device (Mounjaro KwikPen or Zepbound pen). No reconstitution, mixing, or dilution is required. Each pen contains a fixed dose and is used once then discarded. Available strengths: 2.5 mg/0.5 mL, 5 mg/0.5 mL, 7.5 mg/0.5 mL, 10 mg/0.5 mL, 12.5 mg/0.5 mL, and 15 mg/0.5 mL.

Store refrigerated at 2-8 degrees C (36-46 degrees F) in the original carton to protect from light. Do not freeze. If needed, unopened pens may be stored at room temperature up to 30 degrees C (86 degrees F) for a maximum of 21 days. Discard if exposed to temperatures above 30 degrees C or if the 21-day room temperature window is exceeded.

Tirzepatide dosing FAQ

How much bacteriostatic water should I add to a 15 mg vial of Tirzepatide?

The community standard is 2 mL of bacteriostatic water for a 15 mg Tirzepatide vial. That gives a concentration of 7.50 mg/mL, so a 2.5 mg dose is 33.3 units on a U-100 insulin syringe. Adding 1 mL instead doubles the concentration to 15.00 mg/mL and halves the draw to 16.7 units. Less water = smaller injection volume but harder to measure precisely.

How many syringe units is a 2.5 mg dose of Tirzepatide?

On a standard U-100 insulin syringe, a 2.5 mg dose of Tirzepatide is 33.3 units when the 15 mg vial is reconstituted with 2 mL of bacteriostatic water (7.50 mg/mL). If you use 1 mL of bac water instead, draw 16.7 units (15.00 mg/mL).

What is the standard Tirzepatide dose?

Community-reported protocols for Tirzepatide typically use 2.5 mg–15 mg once weekly via Subcutaneous. 2.5 mg is a common starting dose. Mirrors FDA-approved schedule: 2.5 mg x4 weeks, 5 mg x4 weeks, 7.5 mg x4 weeks, 10 mg x4 weeks, 12.5 mg x4 weeks, then 15 mg maintenance

How long does a vial of Tirzepatide last at 2.5 mg once weekly?

A 15 mg vial of Tirzepatide contains roughly 6 doses at 2.5 mg per injection. At once weekly dosing, that is approximately 42 days (about 6 weeks) of supply per vial. Reconstituted Tirzepatide should generally be used within 28 days when refrigerated.

Where do you inject Tirzepatide?

Tirzepatide is typically injected subcutaneous. Common sites reported in the literature and by users include: Abdomen (at least 2 inches from navel), Front of thigh (middle third), Upper arm (back, upper outer area -- may require assistance). Rotate sites with each injection to reduce localized irritation.

Can I use sterile water instead of bacteriostatic water for Tirzepatide?

Bacteriostatic water (containing 0.9% benzyl alcohol as a preservative) is strongly preferred for multi-dose vials like Tirzepatide because it inhibits microbial growth and lets a single vial be used over multiple weeks. Sterile water has no preservative and should generally be reserved for single-use preparations only.

More on Tirzepatide

⚠

Medical Disclaimer

This website is for educational and informational purposes only. The information provided is not intended to diagnose, treat, cure, or prevent any disease. Always consult with a qualified healthcare professional before using any peptide or supplement.